ELVAF 0.00 Stock Price Evolva Holding SA
Range: | 0.822-2.75 | Vol Avg: | 4 | Last Div: | 0 | Changes: | -2.19 |
Beta: | 0.14 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
Sector: | Healthcare | IPO: | Fri Jan 08 2021 | Empoloyees: | 49 |
CUSIP: | | CIK: | | ISIN: | CH1262055788 | Country: | CH |
CEO: | Mr. Gerhard Lobmaier | Website: | https://www.evolva.com |
Evolva Holding SA discovers, researches, develops, and commercializes nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. It offers various ingredients comprising Veri-te Resveratrol, a nature-made polyphenol that occurs naturally in grapes and other plants, including peanuts, cranberries, and berries; L-Arabinose, a flavoring agent used in Maillard reaction; Valencene, an aroma component of citrus fruit and citrus-derived odorants; Nootkatone, an aroma ingredient of grapefruit obtained via biochemical oxidation of valencene; and Vanillin, a primary component of vanilla bean extract. The company was founded in 2004 and is headquartered in Reinach, Switzerland.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.